OnKure Therapeutics, Inc. (OKUR) Ownership
OKUR ownership summary
as of October 18, 2026- Institutions
- 93.4% of shares outstanding
- Insiders
- 10.17% of shares outstanding
- Shares outstanding
- 40.5M
- Float
- 18.7M shares available to trade
- Short interest
- 3.36% 1.2M shares short
- Days to cover
- 6.02 short interest down 11.0% vs prior month
- Institutions 93.39%
- Insiders 10.17%
OKUR top institutional holders
20 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | RA Capital Management, LLC | 9.87% | 4.0M | $8.4M | — | June 30, 2026 |
| 2 | Bvf Inc | 7.99% | 3.2M | $6.8M | +1.3M (+63.5%) | June 30, 2026 |
| 3 | StepStone Group LLC | 6.57% | 2.7M | $5.6M | — | June 30, 2026 |
| 4 | ADAR1 Capital Management LLC | 5.53% | 2.2M | $4.7M | −196,257 (−8.1%) | June 30, 2026 |
| 5 | Vivo Capital, LLC | 4.76% | 1.9M | $4.0M | — | June 30, 2026 |
| 6 | Vestal Point Capital LP | 4.51% | 1.8M | $3.8M | −14,120 (−0.8%) | June 30, 2026 |
| 7 | BlackRock Inc | 3.70% | 1.5M | $3.1M | +1.5M (+2,924.7%) | June 30, 2026 |
| 8 | Trails Edge Capital Partners, LP | 3.55% | 1.4M | $3.0M | +1.4M (0.0%) | June 30, 2026 |
| 9 | Vanguard Capital Management, LLC | 3.55% | 1.4M | $3.0M | +854,562 (+146.7%) | June 30, 2026 |
| 10 | Adage Capital Partners Gp LLC | 2.98% | 1.2M | $2.5M | — | June 30, 2026 |
| 11 | Citadel Advisors Llc | 2.93% | 1.2M | $2.5M | +1.1M (+3,058.1%) | June 30, 2026 |
| 12 | Sio Capital Management, LLC | 2.66% | 1.1M | $2.3M | — | June 30, 2026 |
| 13 | Prosight Management, LP | 2.42% | 979K | $2.1M | −1.2M (−54.6%) | June 30, 2026 |
| 14 | Logos Global Management LP | 2.38% | 964K | $2.0M | +963,855 (0.0%) | June 30, 2026 |
| 15 | Geode Capital Management, LLC | 1.79% | 724K | $1.5M | +625,688 (+633.6%) | June 30, 2026 |
| 16 | NEA Management Company, LLC | 1.18% | 479K | $1.0M | — | June 30, 2026 |
| 17 | State Street Corp | 1.14% | 464K | $973,690 | +450,200 (+3,344.2%) | June 30, 2026 |
| 18 | Ensign Peak Advisors Inc | 1.07% | 432K | $906,425 | +431,631 (0.0%) | June 30, 2026 |
| 19 | Renaissance Technologies Corp | 0.89% | 359K | $753,350 | −18,512 (−4.9%) | June 30, 2026 |
| 20 | Sofinnova Ventures | 0.79% | 322K | $675,553 | +179,992 (+127.0%) | June 30, 2026 |
Value at the latest close. Change = shares bought or sold in the latest quarterly filing (13F). In the top 20, 10 holders added 8.8M shares and 4 cut 1.4M.
OKUR top mutual fund and ETF holders
20 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | Vanguard MStar Total Stk Mkt Idx Invest | 2.85% | 1.2M | $2.4M | — | August 31, 2026 |
| 2 | iShares Russell 2000 ETF | 1.41% | 572K | $1.2M | −6,592 (−1.1%) | September 30, 2026 |
| 3 | Fidelity Small Cap Index | 0.70% | 286K | $599,571 | +1,966 (+0.7%) | July 31, 2026 |
| 4 | iShares Russell 2000 Value ETF | 0.57% | 229K | $480,621 | +348 (+0.2%) | September 30, 2026 |
| 5 | Vanguard Russell 2000 ETF | 0.37% | 151K | $316,867 | +3,000 (+2.0%) | August 31, 2026 |
| 6 | Fidelity Extended Market Index | 0.33% | 135K | $283,658 | −726 (−0.5%) | August 31, 2026 |
| 7 | iShares Micro-Cap ETF | 0.21% | 84K | $175,369 | −576 (−0.7%) | September 30, 2026 |
| 8 | T. Rowe Price Health Care ETF | 0.19% | 79K | $165,530 | +6,835 (+9.5%) | September 30, 2026 |
| 9 | Fidelity Total Market Index | 0.19% | 78K | $163,823 | — | August 31, 2026 |
| 10 | Schwab Small Cap Index | 0.16% | 64K | $133,644 | — | August 31, 2026 |
| 11 | EA Bridgeway Ultra-Small Company Mkt ETF | 0.13% | 53K | $111,871 | — | September 30, 2026 |
| 12 | Fidelity Series Total Market Index | 0.13% | 52K | $108,221 | −5,620 (−9.8%) | August 31, 2026 |
| 13 | iShares Russell 2000 Small-Cap Idx Instl | 0.12% | 49K | $102,892 | — | August 31, 2026 |
| 14 | Fidelity Small Cap Value Index | 0.09% | 37K | $76,782 | — | July 31, 2026 |
| 15 | Fidelity VIP Disciplined Small Cap Init | 0.09% | 36K | $74,871 | +35,653 (0.0%) | July 31, 2026 |
| 16 | Nuveen Small Cap Blend Idx R6 | 0.09% | 35K | $74,344 | — | August 31, 2026 |
| 17 | Dimensional US Small Cap ETF | 0.08% | 32K | $68,095 | — | September 30, 2026 |
| 18 | Avantis US Small Cap Equity ETF | 0.08% | 31K | $64,312 | — | September 30, 2026 |
| 19 | Fidelity Nasdaq Composite Index | 0.07% | 27K | $56,062 | — | August 31, 2026 |
| 20 | EQ/2000 Managed Volatility IB | 0.07% | 26K | $55,375 | — | August 31, 2026 |
Funds report holdings monthly or quarterly; dates differ by fund.
OKUR insider transactions
latest 10| Date | Name | Transaction | Price | Shares | Value |
|---|---|---|---|---|---|
| 2026-03-23 | Jason A Leverone | Sell | $4.16 | 301 | $1,252 |
| 2026-03-23 | Nicholas A Saccomano | Sell | $4.16 | 86 | $358 |
| 2025-12-22 | Jason A Leverone | Sell | $2.97 | 302 | $897 |
| 2025-12-22 | Nicholas A Saccomano | Sell | $2.97 | 87 | $258 |
| 2025-09-22 | Jason A Leverone | Sell | $2.62 | 303 | $794 |
| 2025-09-22 | Nicholas A Saccomano | Sell | $2.62 | 88 | $231 |
| 2025-06-23 | Jason A Leverone | Sell | $2.38 | 303 | $721 |
| 2025-06-23 | Nicholas A Saccomano | Sell | $2.38 | 88 | $209 |
| 2025-05-15 | Cormorant Asset Management, Lp | Sell | $1.85 | 1,813,439 | $3.4M |
| 2025-05-12 | Cormorant Asset Management, Lp | Sell | $1.99 | 24,300 | $48,357 |
Reported trades by company officers, directors and other filers (including disclosures by members of Congress where EODHD lists them). "—" where the filing gives no share count.
OKUR shares outstanding
Year-end shares outstanding, adjusted for splits.
Who owns OKUR
Institutional investors own 93.4% of OnKure Therapeutics's shares and insiders 10.17%. The largest holder is RA Capital Management, LLC with 9.87% of the shares (4.0M), as of June 30, 2026. Among the top 20 institutions, 10 added shares and 4 reduced their stake in the latest filings. Short interest is 3.36% of the float, or 6.02 days of average trading volume. The share count rose 575.8% since 2021.
Related: OKUR analyst forecast, OKUR key metrics. See the OKUR stock overview for the latest quote and news.
OKUR ownership FAQ
Who owns the most OnKure Therapeutics stock?
The largest shareholders of OnKure Therapeutics are RA Capital Management, LLC (9.87%), Bvf Inc (7.99%), StepStone Group LLC (6.57%), ADAR1 Capital Management LLC (5.53%), Vivo Capital, LLC (4.76%).
What percentage of OnKure Therapeutics is owned by institutions?
Institutions hold 93.4% of OnKure Therapeutics's shares outstanding; insiders hold 10.17%.
Which funds own OnKure Therapeutics?
The largest fund holders of OnKure Therapeutics are Vanguard MStar Total Stk Mkt Idx Invest (2.85%), iShares Russell 2000 ETF (1.41%), Fidelity Small Cap Index (0.70%), iShares Russell 2000 Value ETF (0.57%), Vanguard Russell 2000 ETF (0.37%).
What is OnKure Therapeutics's short interest?
1.2M shares of OnKure Therapeutics were sold short, 3.36% of the float; at the average daily volume it would take 6.02 days to cover.
Are insiders buying or selling OnKure Therapeutics?
Of the latest 10 reported insider transactions in OnKure Therapeutics (since May 12, 2025), 0 were purchases and 10 were sales.
How many shares of OnKure Therapeutics are outstanding?
OnKure Therapeutics has 40.5M shares outstanding, of which 18.7M are in the public float.